Table 2.

Variation of T2D Prevalence Between Global Regions in 2019 and Projections for 2030 and 2045

Region	Diabetes Patients in 2019 (20–79 Years) Millions	Comparative Diabetes Prevalence (20–79 Years) %	Diabetes Patients in 2030 (20–79 Years) Millions	Comparative Diabetes Prevalence (20–79 Years) %	Diabetes Patients in 2045 (20–79 Years) Millions	Comparative Diabetes Prevalence (20–79 Years) %
Africa	19.4	4.7	28.6	5.1	47.1	5.2
Europe	59.3	6.3	66	7.3	68.1	7.8
North America and Caribbean	47.6	11.1	56	12.3	63.2	13
Middle-East and North Africa	54.8	12.2	76	13.3	107.6	13.9
South-East Asia	87.6	11.3	115.1	12.2	152.8	12.6
South and Central America	31.6	8.5	40.2	9.5	49.1	9.9
Western Pacific	162.2	11.4	196.5	12.4	212.2	12.8

Notes: Adapted from Diabetes Res Clin Pract, 2, Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. 157, copyright (2019), with permission from Elsevier.⁶²